Bence Szilágyi - Search Results

Year	Number of Results
2013	1
2018	4
2019	1
2021	2
2022	0

1

Discovery of selective fragment-sized immunoproteasome inhibitors.

Kollár L, Gobec M, Szilágyi B, Proj M, Knez D, Ábrányi-Balogh P, Petri L, Imre T, Bajusz D, Ferenczy GG, Gobec S, Keserű GM, Sosič I. Kollár L, et al. Among authors: szilagyi b. Eur J Med Chem. 2021 Jul 5;219:113455. doi: 10.1016/j.ejmech.2021.113455. Epub 2021 Apr 20. Eur J Med Chem. 2021. PMID: 33894528

2

Synthesis and characterization of new fluorescent boro-β-carboline dyes.

Szepesi Kovács D, Hajdu I, Mészáros G, Wittner L, Meszéna D, Tóth EZ, Hegedűs Z, Ranđelović I, Tóvári J, Szabó T, Szilágyi B, Milen M, Keserű GM, Ábrányi-Balogh P. Szepesi Kovács D, et al. Among authors: szilagyi b. RSC Adv. 2021 Apr 1;11(21):12802-12807. doi: 10.1039/d1ra02132j. eCollection 2021 Mar 29. RSC Adv. 2021. PMID: 35423835 Free PMC article.

3

Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies.

Szilágyi B, Ferenczy GG, Keserű GM. Szilágyi B, et al. Expert Opin Drug Discov. 2018 Oct;13(10):973-982. doi: 10.1080/17460441.2018.1524459. Epub 2018 Sep 22. Expert Opin Drug Discov. 2018. PMID: 30220232 Review.

4

Synthesis and Biochemical Evaluation of Lid-Open D-Amino Acid Oxidase Inhibitors.

Szilágyi B, Hargitai C, Kelemen ÁA, Rácz A, Ferenczy GG, Volk B, Keserű GM. Szilágyi B, et al. Molecules. 2019 Jan 14;24(2):290. doi: 10.3390/molecules24020290. Molecules. 2019. PMID: 30646619 Free PMC article.

5

Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.

Szilágyi B, Kovács P, Ferenczy GG, Rácz A, Németh K, Visy J, Szabó P, Ilas J, Balogh GT, Monostory K, Vincze I, Tábi T, Szökő É, Keserű GM. Szilágyi B, et al. Bioorg Med Chem. 2018 May 1;26(8):1579-1587. doi: 10.1016/j.bmc.2018.02.004. Epub 2018 Feb 8. Bioorg Med Chem. 2018. PMID: 29472125

6

Discovery of d-amino acid oxidase inhibitors based on virtual screening against the lid-open enzyme conformation.

Szilágyi B, Skok Ž, Rácz A, Frlan R, Ferenczy GG, Ilaš J, Keserű GM. Szilágyi B, et al. Bioorg Med Chem Lett. 2018 Jun 1;28(10):1693-1698. doi: 10.1016/j.bmcl.2018.04.048. Epub 2018 Apr 20. Bioorg Med Chem Lett. 2018. PMID: 29699925

7

Validation of tautomeric and protomeric binding modes by free energy calculations. A case study for the structure based optimization of D-amino acid oxidase inhibitors.

Orgován Z, Ferenczy GG, Steinbrecher T, Szilágyi B, Bajusz D, Keserű GM. Orgován Z, et al. Among authors: szilagyi b. J Comput Aided Mol Des. 2018 Feb;32(2):331-345. doi: 10.1007/s10822-018-0097-y. Epub 2018 Jan 15. J Comput Aided Mol Des. 2018. PMID: 29335871

8

Synthesis, enzyme kinetics and computational evaluation of N-(β-D-glucopyranosyl) oxadiazolecarboxamides as glycogen phosphorylase inhibitors.

Polyák M, Varga G, Szilágyi B, Juhász L, Docsa T, Gergely P, Begum J, Hayes JM, Somsák L. Polyák M, et al. Among authors: szilagyi b. Bioorg Med Chem. 2013 Sep 15;21(18):5738-47. doi: 10.1016/j.bmc.2013.07.024. Epub 2013 Jul 25. Bioorg Med Chem. 2013. PMID: 23938052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results